SCHEMBL21414404

SCHEMBL21414404

CCCc1ccc(N2CCN(CCO)CCC2=O)cn1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 1/20 0.35
AKR1C3 P42330 1/20 0.34
PKM P14618 1/20 0.34
DRD2 P14416 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20038327 0.83 DRD3 (0.47) ALDH1A1OPRM1OPRL1CYP2C19
SCHEMBL20038358 0.81 ALDH1A1 (0.36) ALDH1A1DRD2OPRM1OPRL1CYP2C19
SCHEMBL20249472 0.80 GAA (0.38) HRH3ALDH1A1AKR1C3OPRM1OPRL1
SCHEMBL20203463 0.80 ALDH1A1 (0.38) HRH3ALDH1A1PKMOPRM1OPRL1
SCHEMBL22650942 0.75 CDK4 (0.34) ALDH1A1OPRM1OPRL1
SCHEMBL22876979 0.74 ALDH1A1 (0.56) HRH3CYP1A2CYP2D6ALDH1A1NPC1
SCHEMBL21414402 0.72 SLC6A2 (0.39) HRH3AKR1C3OPRM1OPRL1
SCHEMBL17226924 0.71 MAPT (0.42) HRH3CYP1A2CYP2D6ALDH1A1DRD2
SCHEMBL20255265 0.69 DRD3 (0.36) HRH3OPRM1OPRL1CYP2C19
SCHEMBL20249309 0.69 GAA (0.37) HRH3ALDH1A1DRD2OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 EP disclosed